ABCL: AbCellera Biologics Inc. Common Shares Company Profile & Statistics

AbCellera Biologics Inc. Common Shares Profile

About

AbCellera Biologics Inc. engages in discovering and developing antibody-based medicines for indications with unmet medical need in the United States. Its product pipeline includes ABCL635 and ABCL575. AbCellera Biologics Inc. is based in Vancouver, Canada.

Info & Links

CEO

Carl L. G. Hansen

Headquarters

150 W 4TH AVENUE
VANCOUVER, A1 V5Y 1G6, CANADA

Auditor

KPMG LLP

Share holders

Employees

562

AbCellera Biologics Inc. Common Shares Statistics

Valuation Measures

Market Capitalization²

1.02B

Enterprise Value

863.89M

Enterprise Value/EBITDA(ttm)

-4.59

Price to Earnings Ratio(ttm)

Price to Sales(ttm)

13.36

Price to Book(mrq)

1.02

Price to Cash(ytd)

Profitability

Gross Margin(ttm)

100.00%

Operating Margin(ttm)

-198.37%

Profit Margin(ttm)

-484.57%

Return on Equity(ttm)

-15.05%

Return on Invested Capital(ttm)

-14.76%

Return on Assets(ttm)

-10.92%

Income Statement

Revenue(ttm)

75.13M

Revenue Per Share(ttm)

0.25

Gross Profit(ttm)

75.13M

EBITDA(ttm)³

-188.28M

Net Income Available to Common(ttm)

-146.41M

Diluted EPS(ttm)

-0.49

Share Statistics

Beta (5Y Monthly)

0.84

52-Week Change

32.21%

S&P 500 52-Week Change

13.39%

S&P 500 Member

Yes

Stock Optionable

Yes

Total Shares Outstanding¹

303.16M

Dividend Yield

0.00%

Float⁴

215.55M

% Held by Insiders

28.90%

% Held by Institutions

61.42%

Balance Sheet

Total Cash(mrq)

558.83M

Total Cash Per Share(mrq)

1.84

Total Debt(mrq)

0.00

Total Debt/Equity(mrq)

0.00%

Current Ratio(mrq)

11.32%

Quick Ratio(mrq)

11.32%

Book Value Per Share(mrq)

3.22

Cash Flow

Operating Cash Flow Per Share(ytd)

-0.44

Free Cash Flow(ytd)

-174.07M

Table Key

mrq = Most Recent Quarter

ttm = Trailing Twelve Months

ytd = Year To Date

Footnotes

Data provided by Zacks Investment Research or calculated by FXEmpire. All numbers are rounded to the closest decimal.

1 Total Shares outstanding is taken from the most recently filed quarterly or annual report.
2 Market Cap is calculated using total shares outstanding and the most recent share price.
3 EBITDA is calculated using methodology that may differ from that used by a company in its reporting.
4 The float is a measure of the number of shares available for trading by the public. It's calculated by taking the number of issued and outstanding shares minus any restricted stock, which might not be publicly traded.

ABCL

AbCellera Biologics Inc. Common Shares